Sol-Gel Technologies Ltd. (SLGL)
71.59
-4.05
(-5.35%)
USD |
NASDAQ |
Oct 07, 16:00
71.59
0.00 (0.00%)
After-Hours: 16:37
Sol-Gel Technologies Net Income (Quarterly) : -3.681M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.681M |
| March 31, 2026 | -3.727M |
| December 31, 2025 | -2.987M |
| September 30, 2025 | -5.942M |
| June 30, 2025 | 11.61M |
| March 31, 2025 | -8.808M |
| December 31, 2024 | -5.846M |
| September 30, 2024 | -0.366M |
| June 30, 2024 | 1.976M |
| March 31, 2024 | -6.344M |
| December 31, 2023 | -4.836M |
| September 30, 2023 | -5.711M |
| June 30, 2023 | -5.97M |
| March 31, 2023 | -10.72M |
| December 31, 2022 | -5.785M |
| September 30, 2022 | -3.407M |
| June 30, 2022 | -0.134M |
| March 31, 2022 | -5.597M |
| December 31, 2021 | 14.03M |
| Date | Value |
|---|---|
| September 30, 2021 | 1.286M |
| June 30, 2021 | -8.033M |
| March 31, 2021 | -4.063M |
| December 31, 2020 | -6.488M |
| September 30, 2020 | -8.62M |
| June 30, 2020 | -7.07M |
| March 31, 2020 | -7.11M |
| December 31, 2019 | -6.602M |
| September 30, 2019 | -7.353M |
| June 30, 2019 | -4.926M |
| March 31, 2019 | -5.728M |
| December 31, 2018 | |
| September 30, 2018 | -7.707M |
| June 30, 2018 | -6.907M |
| March 31, 2018 | -5.713M |
| December 31, 2017 | -5.45M |
| September 30, 2017 | -14.29M |
| June 30, 2017 | -6.202M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -585.89M |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -7.392M |
| Purple Biotech Ltd. | 0.4486M |
| PolyPid Ltd. | -7.849M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.591M |
| Total Expenses (Quarterly) | 4.272M |
| EPS Diluted (Quarterly) | -1.126 |
| Enterprise Value | 200.49M |
| Profit Margin (Quarterly) | -622.8% |
| Earnings Yield | -7.88% |
| Normalized Earnings Yield | -7.884 |